Head and Neck Squamous Cell Carcinoma — Trials

Head and Neck Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,589 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 592
Recruiting: 313
Ph III recruiting: 31
Growth YoY: +30.1%
Industry share: 28%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (247)

clinicaltrialsPublishedShowing 151–200 of 756 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04862650	Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck	active not recruiting	Phase 2	46	Marcelo BonomiOTHER	1	Jun 25, 2026	clinicaltrials
NCT05050162	Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer	suspended	Phase 2 / Phase 3	1,714	NRG OncologyOTHER	5	Jun 25, 2026	clinicaltrials